Walgreens Boots Alliance, Inc. (WBA) Shares Bought by Dana Investment Advisors Inc., Report finds

Walgreens Boots Alliance, Inc. (WBA) Shares Bought by Dana Investment Advisors Inc., Report finds

Dana Investment Advisors Inc. boosted its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 0.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 19,548 shares of the pharmacy operator’s stock after buying an additional 77 shares during the period. Dana Investment Advisors Inc.’s holdings in Walgreens Boots Alliance were worth $1,576,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. First Citizens Bank & Trust Co. raised its position in Walgreens Boots Alliance by 0.9% in the second quarter. First Citizens Bank & Trust Co. now owns 2,470 shares of the pharmacy operator’s stock valued at $206,000 after buying an additional 21 shares during the period. Parsec Financial Management Inc. raised its position in Walgreens Boots Alliance by 24.3% in the second quarter. Parsec Financial Management Inc. now owns 37,537 shares of the pharmacy operator’s stock worth $3,126,000 after buying an additional 7,335 shares during the last quarter. Concert Wealth Management Inc. raised its position in Walgreens Boots Alliance by 8.3% in the second quarter. Concert Wealth Management Inc. now owns 3,920 shares of the pharmacy operator’s stock worth $325,000 after buying an additional 300 shares during the last quarter. Nicolet Bankshares Inc. raised its position in Walgreens Boots Alliance by 10.5% in the second quarter. Nicolet Bankshares Inc. now owns 5,378 shares of the pharmacy operator’s stock worth $448,000 after buying an additional 511 shares during the last quarter. Finally, Penobscot Investment Management Company Inc. raised its position in Walgreens Boots Alliance by 2.5% in the second quarter. Penobscot Investment Management Company Inc. now owns 12,963 shares of the pharmacy operator’s stock worth $1,079,000 after buying an additional 320 shares during the last quarter. 60.15% of the stock is currently owned by institutional investors.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) traded up 0.12% during trading on Wednesday, reaching $81.53. The company had a trading volume of 2,515,251 shares. Walgreens Boots Alliance, Inc. has a 12 month low of $73.88 and a 12 month high of $88.00. The firm has a market capitalization of $88.00 billion, a price-to-earnings ratio of 21.57 and a beta of 1.20. The stock has a 50 day moving average price of $82.68 and a 200 day moving average price of $82.14.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Thursday, January 5th. The pharmacy operator reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.09 by $0.01. Walgreens Boots Alliance had a return on equity of 16.76% and a net margin of 3.52%. The company had revenue of $28.50 billion for the quarter. During the same quarter last year, the business posted $1.03 earnings per share. The firm’s revenue for the quarter was down 1.8% compared to the same quarter last year. On average, equities research analysts predict that Walgreens Boots Alliance, Inc. will post $5.00 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, March 10th. Stockholders of record on Wednesday, February 15th will be given a dividend of $0.375 per share. This represents a $1.50 annualized dividend and a dividend yield of 1.84%. The ex-dividend date is Monday, February 13th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 39.68%.

WBA has been the topic of a number of recent research reports. Leerink Swann set a $90.00 target price on Walgreens Boots Alliance and gave the company a “buy” rating in a report on Sunday, January 8th. Deutsche Bank AG reissued a “buy” rating and issued a $88.00 target price on shares of Walgreens Boots Alliance in a report on Friday, January 6th. Jefferies Group LLC reissued a “buy” rating and issued a $95.00 target price on shares of Walgreens Boots Alliance in a report on Friday, January 6th. Finally, Zacks Investment Research raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $94.00 target price on the stock in a report on Tuesday, January 17th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and twelve have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $91.38.

In other news, EVP Kathleen Wilson-Thompson sold 5,700 shares of Walgreens Boots Alliance stock in a transaction on Monday, November 28th. The stock was sold at an average price of $85.05, for a total transaction of $484,785.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Janice M. Babiak purchased 600 shares of the stock in a transaction dated Thursday, February 2nd. The shares were purchased at an average price of $80.68 per share, for a total transaction of $48,408.00. Following the completion of the transaction, the director now owns 600 shares in the company, valued at approximately $48,408. The disclosure for this purchase can be found here. 13.50% of the stock is currently owned by company insiders.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Related posts

Leave a Comment

Walgreens Boots Alliance, Inc. (WBA) Shares Bought by Dana Investment Advisors Inc.

Walgreens Boots Alliance, Inc. (WBA) Shares Bought by Dana Investment Advisors Inc.

Dana Investment Advisors Inc. boosted its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 0.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 19,548 shares of the pharmacy operator’s stock after buying an additional 77 shares during the period. Dana Investment Advisors Inc.’s holdings in Walgreens Boots Alliance were worth $1,576,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. First Citizens Bank & Trust Co. raised its position in Walgreens Boots Alliance by 0.9% in the second quarter. First Citizens Bank & Trust Co. now owns 2,470 shares of the pharmacy operator’s stock valued at $206,000 after buying an additional 21 shares during the period. Parsec Financial Management Inc. raised its position in Walgreens Boots Alliance by 24.3% in the second quarter. Parsec Financial Management Inc. now owns 37,537 shares of the pharmacy operator’s stock worth $3,126,000 after buying an additional 7,335 shares during the last quarter. Concert Wealth Management Inc. raised its position in Walgreens Boots Alliance by 8.3% in the second quarter. Concert Wealth Management Inc. now owns 3,920 shares of the pharmacy operator’s stock worth $325,000 after buying an additional 300 shares during the last quarter. Nicolet Bankshares Inc. raised its position in Walgreens Boots Alliance by 10.5% in the second quarter. Nicolet Bankshares Inc. now owns 5,378 shares of the pharmacy operator’s stock worth $448,000 after buying an additional 511 shares during the last quarter. Finally, Penobscot Investment Management Company Inc. raised its position in Walgreens Boots Alliance by 2.5% in the second quarter. Penobscot Investment Management Company Inc. now owns 12,963 shares of the pharmacy operator’s stock worth $1,079,000 after buying an additional 320 shares during the last quarter. 60.15% of the stock is currently owned by institutional investors.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) traded up 0.12% during trading on Wednesday, reaching $81.53. The company had a trading volume of 2,515,251 shares. Walgreens Boots Alliance, Inc. has a 12 month low of $73.88 and a 12 month high of $88.00. The firm has a market capitalization of $88.00 billion, a price-to-earnings ratio of 21.57 and a beta of 1.20. The stock has a 50 day moving average price of $82.68 and a 200 day moving average price of $82.14.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Thursday, January 5th. The pharmacy operator reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.09 by $0.01. Walgreens Boots Alliance had a return on equity of 16.76% and a net margin of 3.52%. The company had revenue of $28.50 billion for the quarter. During the same quarter last year, the business posted $1.03 earnings per share. The firm’s revenue for the quarter was down 1.8% compared to the same quarter last year. On average, equities research analysts predict that Walgreens Boots Alliance, Inc. will post $5.00 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, March 10th. Stockholders of record on Wednesday, February 15th will be given a dividend of $0.375 per share. This represents a $1.50 annualized dividend and a dividend yield of 1.84%. The ex-dividend date is Monday, February 13th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 39.68%.

WBA has been the topic of a number of recent research reports. Leerink Swann set a $90.00 target price on Walgreens Boots Alliance and gave the company a “buy” rating in a report on Sunday, January 8th. Deutsche Bank AG reissued a “buy” rating and issued a $88.00 target price on shares of Walgreens Boots Alliance in a report on Friday, January 6th. Jefferies Group LLC reissued a “buy” rating and issued a $95.00 target price on shares of Walgreens Boots Alliance in a report on Friday, January 6th. Finally, Zacks Investment Research raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $94.00 target price on the stock in a report on Tuesday, January 17th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and twelve have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $91.38.

In other news, EVP Kathleen Wilson-Thompson sold 5,700 shares of Walgreens Boots Alliance stock in a transaction on Monday, November 28th. The stock was sold at an average price of $85.05, for a total transaction of $484,785.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Janice M. Babiak purchased 600 shares of the stock in a transaction dated Thursday, February 2nd. The shares were purchased at an average price of $80.68 per share, for a total transaction of $48,408.00. Following the completion of the transaction, the director now owns 600 shares in the company, valued at approximately $48,408. The disclosure for this purchase can be found here. 13.50% of the stock is currently owned by company insiders.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Related posts

Leave a Comment